Genome Dividends and Buybacks
Dividend criteria checks 0/6
Genome does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.03%
Buyback Yield
| Total Shareholder Yield | -0.03% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Positive Sentiment Still Eludes Genome & Company (KOSDAQ:314130) Following 31% Share Price Slump
Nov 13
Positive Sentiment Still Eludes Genome & Company (KOSDAQ:314130) Following 31% Share Price Slump
Sep 06Is Genome (KOSDAQ:314130) A Risky Investment?
Jul 03Investors Still Aren't Entirely Convinced By Genome & Company's (KOSDAQ:314130) Revenues Despite 49% Price Jump
May 27Positive Sentiment Still Eludes Genome & Company (KOSDAQ:314130) Following 25% Share Price Slump
Apr 11Is Genome (KOSDAQ:314130) Using Debt In A Risky Way?
Mar 08Genome (KOSDAQ:314130) Is In A Good Position To Deliver On Growth Plans
Mar 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A314130's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A314130's dividend payments have been increasing.
Dividend Yield vs Market
| Genome Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A314130) | n/a |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Biotechs) | 0.5% |
| Analyst forecast (A314130) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate A314130's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A314130's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A314130's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A314130 has not reported any payouts.